文献速递银屑病与炎症性皮肤病皮肤感染

英格兰泛发性脓疱型银屑病发病率、患病率及预期寿命:基于人群的队列研究

Incidence, prevalence, and life expectancy of patients with generalised pustular psoriasis in England: a population-based cohort study exploring ethnic and sex variations.
PubMed 文献 · Br J Dermatol · 2026-09-21

该研究利用英格兰临床实践研究数据链(2008-2022年)纳入991例泛发性脓疱型银屑病(GPP)患者,分析其患病率、发病率、死亡风险及预期寿命。结果显示GPP患病率从20.9/百万升至32.5/百万,全因死亡风险为无GPP者的3.19倍(aHR 3.19; 95%CI 2.58-3.91),且脓毒症死亡风险尤其高(aHR 9.76; 95%CI 4.92-19.35)。

要点

  • GPP患病率15年间增长超50%,女性、亚裔及老年人群患病率更高。
  • GPP患者全因死亡风险较对照高3倍以上,脓毒症死亡风险近10倍。
  • 诊断年龄越轻,预期寿命损失越大,需早期识别与干预。

核心结论

  • 英格兰GPP患病率15年间增加超过50%,存在性别和种族差异。
  • GPP与全因及特定原因死亡风险升高相关,并导致预期寿命缩短。

研究设计与样本

  • 基于人群的队列研究,使用临床实践研究数据链链接医院、死亡、贫困和种族记录。
  • 将新发GPP患者与最多10名无GPP对照进行匹配,采用灵活参数生存模型估计调整风险比,并用简略寿命表估计寿命损失年。

主要发现

  • GPP患病率从2008年的20.9/百万升至2022年的32.5/百万,女性、亚裔及老年组患病率更高。
  • 发病率在2016年前保持稳定,之后呈上升趋势,达到4.9/百万 person-years。
  • 平均发病年龄(标准差)为51.4(21.2)岁,亚裔人群发病早于白人。
  • 全因死亡风险为无GPP者的3.19倍(aHR 3.19; 95%CI 2.58-3.91)。
  • 肿瘤、呼吸系统、消化系统和循环系统疾病死亡风险升高,脓毒症风险尤其高(aHR 9.76; 95%CI 4.92-19.35)。

临床怎么用

  • 临床应关注GPP患者脓毒症等感染风险的监测与预防。
  • 对年轻发病的GPP患者需加强长期随访和共病管理。
  • 针对女性、亚裔及老年人群可考虑更积极的筛查与干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Generalised pustular psoriasis (GPP) is a rare, severe inflammatory skin disease associated with significant morbidity and increased mortality. Population-based data on the epidemiology of GPP examining ethnic and sex differences, and life-expectancy, remain scarce. OBJECTIVES: To examine the epidemiology of GPP in England over a 15-year period (2008-2022), all-cause and cause-specific mortality risk associated with GPP, and life expectancy including years of life lost associated with age at diagnosis. METHODS: A population-based cohort study using the Clinical Practice Research Datalink linked with hospital, mortality, deprivation, and ethnicity records. Patients with a diagnosis of GPP from primary care or hospital records were identified. Annual prevalence and incidence rates were calculated. Individuals with incident GPP were matched with up to 10 comparators without GPP. Flexible parametric survival models estimated adjusted hazard ratios (aHRs) for the association between GPP and mortality. Abridged life tables were used to estimate years of life lost. RESULTS: Among 25.8 million people, 991 with GPP were identified (63% female; 86% White, 10% Asian, 3% Black/Mixed/Other). GPP prevalence increased from 20.9 per million in 2008 to 32.5 per million in 2022, with higher rates in females, the Asian population, and older age groups. Incidence remained stable until 2016, followed by an upward trend reaching 4.9 per million person-years. Mean age (SD) at onset was 51.4 (21.2) years, occurring earlier in Asian people than in White people. All-cause mortality risk was over three times higher for patients with GPP compared with people without GPP (aHR 3.19; 95% CI 2.58-3.91). Death rates were elevated with GPP for neoplasms, respiratory, digestive, and circulatory diseases, and particularly sepsis (aHR 9.76 [4.92-19.35]). A younger age at diagnosis of GPP was associated with the greatest reduction in life expectancy. CONCLUSIONS: Over the past 15 years, the prevalence of GPP in England increased by more than 50%, with notable differences by sex and ethnicity. GPP was associated with elevated risks of all-cause and cause-specific mortality and reductions in life expectancy. These findings highlight the clinical burden of GPP and the need for appropriate and targeted strategies to reduce preventable morbidity and mortality.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Wright AK, de Fátima Cobre A, Dimmock PW, et al. Incidence, prevalence, and life expectancy of patients with generalised pustular psoriasis in England: a population-based cohort study exploring ethnic and sex variations. Br J Dermatol. 2026. PMID: 42765197. doi:10.1093/bjd/ljag417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。